Posts Tagged ‘biotech’
On the future of personal genomics and the law…
Friday, July 2, 2010, 1:51 pm
Dan Vorhaus
Dan Vorhaus is a lawyer with Robinson Bradshaw and Hinson in Charlotte, N.C. where a portion of his practice comprises the growing field of personal genomics law. Given the interest in personal genomics in the Triangle, I thought I’d create an expanded version of the short question-and-answer interview I did with him for an up-coming issue of the Sci-Tech section in the Charlotte Observer and the Raleigh News and Observer (be on the lookout for that next Monday in print and online), and post it here. Vorhaus also authors the Genomics Law Report, a blog about the legal side of personal genomics, and he will be giving testimony to the Food and Drug Administration in the near future as the agency attempts to sort out particulars of how it plans to regulate genomic diagnostic testing.
How did you become interested in concentrating on personal genomics as an area of the law?
I have a master’s in bioethics; I did that degree before I went to law school. So as I started thinking about the areas of law and policy that were most interesting to me, that was clearly one of them. And it seemed like there was a tremendous opportunity for a field that is developing and emerging and creating all sorts of new and exciting legal issues. And it’s something that I’ve always had an interest in the underlying science and technology, and I was fortunate enough in law school to start working with some real pioneers in the field, specifically George Church in the personal genome field. Everything sort of built from there. Now, it’s how I make my living, it’s my career. And I love it. It’s something new and fascinating every single day and I can’t get enough of it.
Gephardt visits Triangle on tour to spur medical innovation
Wednesday, June 30, 2010, 2:12 pmDick Gephardt is traveling across the country to reinvigorate medical innovation and on Wednesday the former Congressman, U.S. House majority leader and two-time Democratic presidential candidate visited North Carolina, a U.S. biotech hot spot.
U.S. Rep. Dick Gephardt
He carried a to-do list with him that he plans to take to Congress and the Obama Administration.
Changing the way the Food and Drug Administration regulates the development of new medicines, making the research and development tax credit for companies permanent and establishing a federal office to spearhead public-private partnerships between universities, the National Institutes of Health and R&D companies were among the suggestions on the list.
“It needs to be the new space program in my view,” Gephardt told about 100 people at the packed Capital City Club in Raleigh. Read more…
Needed: Cash to pay for innovation
Thursday, February 25, 2010, 1:02 amA $500 ticket to the Biotech conference Monday and Tuesday offered face time with heavy-hitting investors. After an 18-month, deep recession that dried up funding for drug research and development nationwide, it was a lure that attracted Research Triangle area companies to the Raleigh Convention Center in droves.
The visitors made it clear they and other investors remain skittish, but they also noted signs of hope, such as the handful of initial public offerings by biotech companies in past months and an adjustment in venture funding last year in favor of early-stage companies.
Stephen Sands
“When we look at a year ago, we’re really all taking a breath of relief that the Dow [Jones stock index] is over 10,000,” said Stephen Sands, vice chairman of U.S. investment banking in Lazard’s healthcare group, who moderated a panel addressing the future of biotech funding at the conference. Read more…
RTP Weekahead 2/22
Sunday, February 21, 2010, 9:21 pmEvents taking place the week of Feb. 22 in the Research Triangle area that are open to the public: Read more…
RTP Wrapup 2/12
Thursday, February 11, 2010, 11:53 pmBayer CropScience is on the hook for $1.5 million after a jury verdict, former Gov. Jim Hunt tries to stoke the Research Triangle area’s creative juices at this year’s Emerging Issues Forum and RTI International scientists dipped into their nanotech tool box to come up with a better lightbulb. Read more…
In Holly Springs, Novartis leaves chicken out of flu vaccine recipe
Tuesday, November 24, 2009, 8:22 amThe flu vaccine manufacturing plant that Novartis is about to finish about 20 miles southwest of North Carolina’s Research Triangle Park promises better and faster protection for humans without the carnage to chicken offspring.
RTP looks toward China
Wednesday, November 11, 2009, 4:56 pmForty years after “Made in Japan” was synonymous with cheap, poorly made goods, Japanese technology rules the U.S. automotive industry. The same could happen with biosciences “Made in China,” just faster.
RTP Weekahead 9/21
Sunday, September 20, 2009, 5:44 pmEvents taking place the week of Sept. 21 in the Research Triangle area that are open to the public:
RTP Weekahead 9/14
Sunday, September 13, 2009, 5:35 pmEvents taking place the week of Sept. 14 in the Research Triangle area that are open to the public:
RTP Wrapup 9/11
Thursday, September 10, 2009, 9:39 pmGlaxoSmithKline gets good news on its Cervarix vaccine and bad news on its blockbuster asthma treatment Advair, the N.C. Biotechnology Center prepares to build a $10.4 million expansion with the help of private donations and Quintiles Transnational gets ready for Clinical Research Education Day at N.C. Central University.
